Wall Street analysts expect that RTI Surgical Inc (NASDAQ:RTIX) will post sales of $70.16 million for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for RTI Surgical’s earnings, with the highest sales estimate coming in at $70.82 million and the lowest estimate coming in at $69.49 million. RTI Surgical posted sales of $71.35 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 1.7%. The company is expected to issue its next earnings report on Thursday, February 22nd.

According to Zacks, analysts expect that RTI Surgical will report full-year sales of $70.16 million for the current fiscal year, with estimates ranging from $278.40 million to $279.56 million. For the next year, analysts anticipate that the business will post sales of $282.10 million per share, with estimates ranging from $281.94 million to $282.26 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that follow RTI Surgical.

RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.01. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The business had revenue of $66.69 million for the quarter, compared to analysts’ expectations of $65.63 million. The business’s revenue for the quarter was up .2% on a year-over-year basis.

Several analysts have issued reports on the company. BidaskClub cut RTI Surgical from a “hold” rating to a “sell” rating in a research note on Tuesday, December 5th. Zacks Investment Research upgraded RTI Surgical from a “sell” rating to a “hold” rating in a research note on Friday, October 13th.

RTI Surgical (RTIX) opened at $4.20 on Wednesday. The company has a quick ratio of 1.21, a current ratio of 3.34 and a debt-to-equity ratio of 0.25. RTI Surgical has a one year low of $3.01 and a one year high of $6.00. The company has a market capitalization of $249.94, a PE ratio of 112.50, a P/E/G ratio of 6.00 and a beta of 1.76.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC raised its stake in RTI Surgical by 3.7% during the first quarter. Geode Capital Management LLC now owns 456,346 shares of the medical equipment provider’s stock valued at $1,825,000 after buying an additional 16,235 shares in the last quarter. AJO LP acquired a new stake in RTI Surgical during the second quarter valued at approximately $2,597,000. Strs Ohio raised its position in shares of RTI Surgical by 19.5% during the 3rd quarter. Strs Ohio now owns 142,300 shares of the medical equipment provider’s stock worth $647,000 after purchasing an additional 23,200 shares during the period. Menta Capital LLC raised its position in shares of RTI Surgical by 51.5% during the 2nd quarter. Menta Capital LLC now owns 160,958 shares of the medical equipment provider’s stock worth $942,000 after purchasing an additional 54,685 shares during the period. Finally, Ameriprise Financial Inc. raised its position in shares of RTI Surgical by 91.8% during the 2nd quarter. Ameriprise Financial Inc. now owns 85,937 shares of the medical equipment provider’s stock worth $503,000 after purchasing an additional 41,130 shares during the period. Hedge funds and other institutional investors own 69.92% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/12/13/zacks-brokerages-anticipate-rti-surgical-inc-rtix-will-announce-quarterly-sales-of-70-16-million.html.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.